Credit Agricole’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$195M Sell
897,538
-22,890
-2% -$5.08M 0.51% 28
2025
Q4
$210M Buy
920,428
+187,850
+26% +$42.8M 0.48% 35
2025
Q3
$170M Buy
+732,578
New +$149M 0.45% 36
2025
Q1
$141M Buy
674,841
+111,489
+20% +$21.7M 0.44% 43
2024
Q4
$100M Buy
563,352
+219,479
+64% +$40.4M 0.29% 63
2024
Q3
$67.9M Buy
343,873
+75,509
+28% +$14.1M 0.29% 66
2024
Q2
$46M Buy
268,364
+136,561
+104% +$22.6M 0.25% 81
2024
Q1
$21.7M Buy
131,803
+45,573
+53% +$7.85M 0.23% 78
2023
Q4
$13.4M Buy
86,230
+6,014
+7% +$877K 0.15% 115
2023
Q3
$12M Buy
80,216
+39,714
+98% +$5.83M 0.19% 103
2023
Q2
$5.46M Buy
40,502
+1,389
+4% +$204K 0.1% 164
2023
Q1
$6.23M Sell
39,113
-12,185
-24% -$1.86M 0.13% 132
2022
Q4
$8.29M Buy
51,298
+17,761
+53% +$2.72M 0.17% 109
2022
Q3
$4.5M Buy
33,537
+4,296
+15% +$616K 0.09% 151
2022
Q2
$4.48M Sell
29,241
-4,415
-13% -$675K 0.11% 156
2022
Q1
$5.46M Buy
33,656
+27,263
+426% +$3.96M 0.1% 149
2021
Q4
$865K Sell
6,393
-25,198
-80% -$2.98M 0.01% 304
2021
Q3
$3.41M Buy
31,591
+4,422
+16% +$505K 0.06% 181
2021
Q2
$3.06M Buy
27,169
+18,790
+224% +$2.12M 0.06% 194
2021
Q1
$907K Sell
8,379
-3,943
-32% -$422K 0.02% 237
2020
Q4
$1.32M Sell
12,322
-593
-5% -$57K 0.04% 196
2020
Q3
$1.13M Buy
12,915
+4,359
+51% +$410K 0.06% 181
2020
Q2
$840K Sell
8,556
-679
-7% -$59.8K 0.05% 192
2020
Q1
$703K Buy
9,235
+2,372
+35% +$202K 0.06% 173
2019
Q4
$608K Hold
6,863
0.03% 190
2019
Q3
$519K Buy
+6,863
New +$471K 0.03% 282
2018
Q3
Sell
-3,902
Closed -$361K 425
2018
Q2
$361K Sell
3,902
-291
-7% -$28.4K 0.03% 288
2018
Q1
$397K Sell
4,193
-60,504
-94% -$6.65M 0.03% 257
2017
Q4
$6.26M Sell
64,697
-1,174,645
-95% -$111M 0.42% 54
2017
Q3
$110M Sell
1,239,342
-97,245
-7% -$7.4M 0.38% 64
2017
Q2
$96.9M Buy
1,336,587
+187,143
+16% +$12.6M 0.32% 74
2017
Q1
$74.9M Buy
1,149,444
+338,927
+42% +$21.3M 0.23% 104
2016
Q4
$50.8M Buy
810,517
+26,030
+3% +$1.59M 0.16% 158
2016
Q3
$49.5M Sell
784,487
-16,561
-2% -$1.07M 0.16% 150
2016
Q2
$49.6M Sell
801,048
-176,266
-18% -$10.7M 0.19% 126
2016
Q1
$55.8M Buy
977,314
+47,766
+5% +$2.66M 0.26% 94
2015
Q4
$55.1M Sell
929,548
-124,950
-12% -$7.2M 0.26% 89
2015
Q3
$57.4M Buy
1,054,498
+44,568
+4% +$2.9M 0.28% 69
2015
Q2
$67.9M Sell
1,009,930
-178,806
-15% -$11.7M 0.32% 65
2015
Q1
$69.6M Sell
1,188,736
-402,036
-25% -$24.3M 0.31% 66
2014
Q4
$106M Sell
1,590,772
-505,269
-24% -$31.9M 0.46% 41
2014
Q3
$121M Buy
2,096,041
+1,100,546
+111% +$61.1M 0.52% 29
2014
Q2
$56.2M Sell
995,495
-213,454
-18% -$11.2M 0.24% 96
2014
Q1
$62.1M Buy
1,208,949
+98,206
+9% +$4.96M 0.25% 101
2013
Q4
$58.7M Sell
1,110,743
-62,423
-5% -$3.07M 0.24% 102
2013
Q3
$52.5M Buy
+1,173,166
New +$52M 0.23% 106

Other funds holding ABBV

Credit Agricole's ABBV Position: Q1 2026 in Review

Credit Agricole reduced its AbbVie (ABBV) stake by 2.5% in Q1 2026, selling an estimated $5.08M and leaving 897,538 shares worth $195M. The position accounts for 0.51% of the portfolio, ranked #28.

Credit Agricole first reported a position in ABBV in Q3 2013 and has held it in 46 quarters since. The position peaked at $210M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Credit Agricole held 897,538 shares of AbbVie worth $195M as of Q1 2026.
  • Credit Agricole sold 22,890 AbbVie shares in Q1 2026, an estimated $5.08M.
  • AbbVie made up 0.51% of Credit Agricole's portfolio in Q1 2026, its #28 holding.
  • Credit Agricole first reported a position in AbbVie in Q3 2013 and has held it in 46 quarters since.
  • Credit Agricole's AbbVie position peaked at $210M in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.